跳至主要内容
临床试验/NCT01083953
NCT01083953已完成不适用

Optimal End-Tidal Concentration of Sevoflurane and Desflurane for Removal of Supreme Laryngeal Mask Airway in Anaesthetized Adults

University of Malaya1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2009年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
1
主要终点
Optimal end tidal concentration of sevoflurane/ desflurane

研究概览

简要总结

The purpose of this study is to determine the optimal volatile anaesthetic (sevoflurane and desflurane) to remove a Supreme LMA in adults in which there is minimal airway response.

Null hypothesis: there is no significant difference between the optimal end tidal concentration of sevoflurane and desflurane for Supreme LMA removal.

详细描述

The manufactures' instructions for removal of the LMA recommend waiting until protective reflexes have returned. However, the appropriate timing for removal remains controversial. A more frequent incidence of airway hyperreactivity and complications has been reported by some studies when the LMA was removed in the awake state versus the anesthetized state. Techniques that reduce the time from LMA removal to the return of protective airway reflexes would minimize the risk of aspiration, contamination, or airway obstruction.

With increasingly common use of Supreme LMA in anaesthetic practice, a safe and suitable depth for removal of the Supreme LMA requires research.

Thus the determination of the optimal end-tidal concentration of commonly used volatile agents ie. Sevoflurane and Desflurane for Supreme LMA removal requires research, both for patient safety and minimising anaesthetic costs in dealing with airway complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 49 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • ASA 1-2 patients
  • Age 18 - 49 years old
  • Elective surgery of short duration ( < 2 hours ) which require local anaesthetic infiltration

排除标准

  • Upper respiratory tract symptoms in the previous 10 days
  • Risk of gastric oesophageal reflux or regurgitation
  • Known or predicted difficult airway
  • Poor dentition with high risk of damage
  • BMI > 30 kg/m2
  • Refusing to participate

研究组 & 干预措施

Sevoflurane

Experimental

1 arm will receive sevoflurane at varying concentrations at which extubation is attempted according to the Dixon up and down method

干预措施: Sevoflurane (Drug)

Desflurane

Experimental

1 arm will receive desflurane at varying end tidal concentration at which extubation will be attempted according to Dixon up and down method

干预措施: Desflurane (Drug)

结局指标

主要结局

Optimal end tidal concentration of sevoflurane/ desflurane

时间窗: 6 months

次要结局

  • presence of airway response(10 mins after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cindy Thomas Joseph

doctor

University of Malaya

研究点 (1)

Loading locations...

相似试验